Information to authors
Polymorphisms of genes, associated with intracellular signaling pathways in juvenile idiopathic arthritis
SUMMARY. The study is aimed at determining changes in the nucleotide sequence in the genes, associated with the ac-tivation of intracellular signaling molecules and the risk of autoimmune dysregulation in patients with juvenile idiopathic arthritis (JIA). The next-generation sequencing (NGS) was performed on Illumina’s HiSeq device (USA) in 36 children diagnosed with JIA. Nucleotide sequence changes were detected in the CASP10, CASP8, IL7R, IL10RA, IL12RB1, IL21R, MYD88, NFKB2, STAT5B, JAK3, IRAK4, UNC13D genes in 13 (36.11 %) patients, of which 7 (53.8 %) children had nucleotide sequence changes in the genes, associated with autoinflammatory syndromes (NOD2, NLRP12, MEFV, ADA2, PSTPIP1). Positive HLA-B27 was in 7 (53.8 %) patients with changes in autoimmunity genes, and only in 2 (8.6 %) children without changes in these genes, which demonstrates the asso-ciativity between HLA and the group of selected genes [OR = 12.25 (CI 1.99-75.19]. Thus, risk loci were identified in the CASP10, CASP8, IL7R, IL10RA, IL12RB1, IL21R, MYD88, NFKB2, STAT5B, JAK3, IRAK4, UNC13D genes in 36.11 % of patients with the JIA phenotype. These genes are associated with the activation of intracellular signaling molecules and initiation of autoimmune dysregulation. The patients with JIA, who had nucleotide sequence changes in autoimmunity genes, were significantly more likely to have mutations in autoinflammatory genes, which demonstrates the possibility of a mixed phenotype of autoimmune and autoinflammatory overlap in some individuals. The study confirms the importance of variable changes in the genes of the NF-kB, JAK/STAT intracellular «signaling» pathways in JIA, which may be informative for future therapeutic strategies when choosing targeted personalized therapeutic tactics.
Key words: children, juvenile idiopathic arthritis, genes, intracellular signaling pathways, autoimmunity, autoinflammation, next-generation sequencing
E-mail: olena.mukvich gmail.com, g.d.telegeev imbg.org.ua, matskevych90 gmail.com, anna_scherban ukr.net
Arakelyan, A., Nersisyan, L., Poghosyan, D., Khondkaryan, L., Hakobyan, A., Löffler-Wirth, H., Melanitou, E., and Binder, H., Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles, PLoS One, 2017, vol. 12, no. 3, art. ID e0187572.
Banerjee, S., Biehl, A., Gadina, M., et al., JAK–STAT Signaling as a target for inflammatory and autoimmune diseases: Current and future prospects, Drugs, 2017, vol. 77, pp. 521–546. https://doi.org/10.1007/s40265-017-0701-9
Baralle, D. and Baralle, M., Splicing in action: assessing disease causing sequence changes, J. Med. Genet., 2005, vol. 42, no. 10, pp. 737–748. PMID: 16199547; PMCID: PMC1735933.https://doi.org/10.1136/jmg.2004.029538
Buratti, E., Chivers, M., Královicová, J., et al., Aber-rant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization, Nucleic Acids Res., 2007, vol. 35, no. 13, pp. 4250–4263. https://doi.org/10.1093/nar/gkm402
Ciccarelli, F., De Martinis, M., and Ginaldi, L., An update on autoinflammatory diseases, Curr. Med. Chem., 2014, vol. 21, no. 3, pp. 261–269.
Conway, D.H., Dara, J., Bagashev, A., and Sullivan, K.E., Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred, J. Allergy Clin. Immunol., 2010, vol. 126, no. 1, pp. 172–175. doi . Cited June 9, 2010. PMID: 20538326https://doi.org/10.1016/j.jaci.2010.04.014
Felgentreff, K., Perez-Becker, R., Speckmann, C., et al., Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency, Clin. Immunol., 2011, vol. 141, no. 1, pp. 73–82.https://doi.org/10.1016/j.clim.2011.05.007
Pagnini, I., Scavone, M., Maccora, I., Mastrolia, M.V., Marrani, E., Bertini, F., Lamot, L., and Simonini, G., The development of extra-articular manifestations in children with enthesitis-related arthritis: natural course or different disease entity?, Front. Med., 2021, vol. 8, art. ID 667305.
Jie, Li., Rong-Shuang, T., Zhou, Shi., and Jin-Qi, Li., Nuclear factor-κB in rheumatoid arthritis, Int. J. Reumatic Dis., 2020, vol. 23, no. 12, pp. 1627–1635. https://doi.org/10.1111/1756-185X.13958
McAllister, K., Eyre, S., and Orozco, G., Genetics of rheumatoid arthritis: GWAS and beyond, Open Access Rheumatol., 2011, vol. 3, pp. 31–46.
Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S.E., and Topper, S.E., Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation, Genome Med., 2017, vol. 9, no. 1, art. ID PMCID: PMC5295186.https://doi.org/10.1186/s13073-017-0403-7
Leiding, J.W., et al., Hypomorphic interleukin-7 receptor α-chain mutations and T-cell deficiency: a delay in diagnosis, Ann. Allergy, Asthma, Immunol., 2015, vol. 115, no. 1, pp. 1–3. PMID: 26123418.
Harigai, M. and Honda, S., Selectivity of Janus kinase Inhibitors in rheumatoid arthritis and other immune-mediated inflammatory diseases: is expectation the root of all headache?, Drugs, 2020, vol. 80, no. 12, pp. 1183–1201.
Oliveira, M.L., Akkapeddi, P., Ribeiro, D., Melão, A., and Barata, J.T., IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update, Adv. Biol. Regul., 2019, vol. 71, pp. 88–96. https://doi.org/10.1016/j.jbior.2018.09.012
O’Shea, J.J. and Plenge, R., JAK and STAT signaling molecules in immunoregulation and immune-mediated disease, Immunity, 2012, vol. 36, no. 4, pp. 542–550.https://doi.org/10.1016/j.immuni.2012.03.014
Salim, P.H. and Xavier, R.M., Influence of genetic polymorphisms (IL-10/CXCL8/CXCR2/NFκB) on the susceptibility of autoimmune rheumatic diseases, Rev. Bras. Reumatol., 2014, vol. 54, no. 4, pp. 301–310.
Petty, R.E., Southwood, T.R., and Manners, P., International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision Edmonton, 2001, J. Rheumatol., 2004, vol. 31, no. 2, pp. 390–392. PMID: 14760812.
Picard, C., von Bernuth, H., Ghandil, P., et al., Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency, Medicine (Baltimore), 2010, vol. 89, no. 6, pp. 403–425. https://doi.org/10.1097/MD.0b013e3181fd8ec3
Robinson, R.T., IL12Rβ1: The cytokine receptor that we used to know, Cytokine, 2015, vol. 71, no. 2, pp. 348–359. https://doi.org/10.1016/j.cyto.2014.11.018
Ringold, S., Sheila, T., Angeles-Han, et al., American College of Rheumatology/Arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis, Arthritis Care Res., 2019, vol. 71, no. 6, pp. 717–734. https://doi.org/10.1002/acr.23870
Sikora, K.A., Bennett, J.R., Vyncke, L., et al., Germline gain-of-function myeloid differentiation primary response gene–88 (MYD88) mutation in a child with severe arthritis, J. Allergy Clin. Immunol., 2018, vol. 141, no. 5, pp. 1943–1947. https://doi.org/10.1016/j.jaci.2018.01.027
Tripodi, S.I., Mazza, C., Moratto, D., Ramenghi, U., Caorsi, R., Gattorno, M., and Badolato, R., Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation, Immunol. Lett., 2016, vol. 177, pp. 22–24. https://doi.org/10.1016/j.imlet.2016.07.001
Wieczorek, M., Ginter, T., Brand, P., Heinzel, T., and Krämer, O.H., Acetylation modulates the STAT signaling code, Cytokine Growth Factor Rev., 2012, vol. 23, no. 6, pp. 293–305. https://doi.org/10.1016/j.cytogfr.2012.06.005
Yang, J. and Stark, G., Roles of unphosphorylated STATs in signaling, Cell Res., 2008, vol. 18, pp. 443–451. https://doi.org/10.1038/cr.2008.41
Yasunaga, M., Manabe, S., and Matsumura, Y., Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease, Sci. Rep., 2017, vol. 7, art. ID 10735. https://doi.org/10.1038/s41598-017-11255-4
Zhu, S., Hsu, A.P., Vacek, M.M., Zheng, L., Schäffer, A.A., Dale, J.K., Davis, J., Fischer, R.E., Straus, S.E., Boruchov, D., Saulsbury, F.T., Lenardo, M.J., and Puck, J.M., Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome, Hum. Genet., 2006, vol. 119, no. 3, pp. 284–294.https://doi.org/10.1007/s00439-006-0138-9
|Coded & Designed by Volodymyr Duplij||Modified 01.02.23|